Using an OV for the purpose of local expression of PD-L1 BiTE not only helps prevent the occurrence of systemic toxicities associated with ‘on-target off-tumor’ effects but also have the ability to overcome the TME immunosuppressive conditions (130). Here, CD274 is linked to neoplasm.